Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP11B2 | P19099 | 8/20 | 0.49 |
| ▸ | CYP11B1 | P15538 | 6/20 | 0.49 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.49 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.45 |
| ▸ | IRAK4 | Q9NWZ3 | 1/20 | 0.40 |
| ▸ | CHRNB2 | P17787 | 2/20 | 0.39 |
| ▸ | CHRNA5 | P30532 | 2/20 | 0.39 |
| ▸ | CHRNA4 | P43681 | 2/20 | 0.39 |
| ▸ | PTGER2 | P43116 | 1/20 | 0.39 |
| ▸ | CDC7 | O00311 | 3/20 | 0.39 |
| ▸ | CDK2 | P24941 | 1/20 | 0.39 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.39 |
| ▸ | NEK1 | Q96PY6 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6654549 | 0.89 | CYP11B2 (0.53) | CYP11B2CYP11B1CYP17A1CYP19A1IRAK4 | |
| SCHEMBL6844281 | 0.85 | CYP11B2 (0.57) | CYP11B2CYP11B1CYP17A1CYP19A1IRAK4 | |
| SCHEMBL28107018 | 0.83 | CYP19A1 (0.56) | CYP11B2CYP11B1CYP17A1CYP19A1CHRNB2 | |
| SCHEMBL6846125 | 0.83 | CYP11B2 (0.59) | CYP11B2CYP11B1CYP17A1CYP19A1 | |
| SCHEMBL6655119 | 0.79 | CYP11B2 (0.51) | CYP11B2CYP11B1CYP17A1CYP19A1 | |
| SCHEMBL6846113 | 0.79 | CYP11B2 (0.48) | CYP11B2CYP11B1CYP17A1CYP19A1 | |
| SCHEMBL6657591 | 0.78 | CYP11B2 (0.56) | CYP11B2CYP11B1CYP17A1CYP19A1 | |
| SCHEMBL6845503 | 0.78 | CYP19A1 (0.39) | CYP11B2CYP11B1CYP17A1CYP19A1PTGER2 | |
| SCHEMBL6658742 | 0.78 | CYP11B2 (0.57) | CYP11B2CYP11B1CYP17A1CYP19A1IRAK4 | |
| SCHEMBL22515743 | 0.78 | CYP11B2 (0.53) | CYP11B2CYP11B1CYP17A1CYP19A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1432698-A2 | SUBSTITUTED 3-PYRIDYL INDOLES AND INDAZOLES AS C17,20 LYASE INHIBITORS | Bayer Pharmaceuticals Corporation (US) | 2004-06-30 | — | — | EP | disclosed |
| WO-2003027094-A2 | SUBSTITUTED 3-PYRIDYL INDOLES AND INDAZOLES AS C17,20 LYASE INHIBITORS | BAYER PHARMACEUTICALS CORPORATION (US) | 2003-04-03 | — | — | WO | disclosed |